These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6060970)

  • 1. Influence of the physical state of formalinized vaccinia virus particles on surviving plaque titer: evidence for multiplicity reactivation.
    Kim KS; Sharp DG
    J Immunol; 1967 Dec; 99(6):1221-5. PubMed ID: 6060970
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiplicity reactivation of vaccinia virus particles treated with nitrogen mustard.
    Kim KS; Sharp DG
    J Virol; 1967 Feb; 1(1):45-9. PubMed ID: 5623957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunodepressive action of vaccinia virus].
    Daniliuk OS; Dzagurov SG; Berdinskikh MS
    Biull Eksp Biol Med; 1982 Jul; 94(7):73-4. PubMed ID: 6889898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purifying the vaccinia virus vaccine by gel filtration].
    Stickl H; Korb W; Hochstein-Mintzel V
    Zentralbl Bakteriol Orig; 1970; 215(1):38-50. PubMed ID: 5487818
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the water content of the vaccinia virus and its hemagglutinin by density gradient centrifugation. 3. The water content of hemagglutinin].
    Schiek W
    Zentralbl Bakteriol Orig; 1968; 208(4):485-92. PubMed ID: 5760501
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
    Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
    Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of recombinant vaccinia virus for veterinary vaccines.
    Yilma T
    Dev Biol Stand; 1994; 82():201-9. PubMed ID: 7958475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Generalized vaccinia on the burned skin in an infant].
    Kostrzewski JM
    Wiad Lek; 1982 Jan; 35(1):75-7. PubMed ID: 7101925
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
    Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of various virulence tests with low virulence vaccinia virus in mice.
    Ludvíková V; Kutinová L; Simonová V; Otavová M
    Biologicals; 1994 Jun; 22(2):187-90. PubMed ID: 7917234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile vaccine.
    Newmark P
    Microbiol Sci; 1984 Apr; 1(1):25. PubMed ID: 6444091
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
    Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
    Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of human immunological responses to vaccinia virus.
    Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
    Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE INFLUENCE OF DEGREE OF AGGREGATION AND VIRUS QUALITY ON THE PLAQUE TITER OF AGGREGATED VACCINIA VIRUS.
    GALASSO GJ; SHARP J; SHARP DG
    J Immunol; 1964 Jun; 92():870-8. PubMed ID: 14210793
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.
    de Waal L; Wyatt LS; Yüksel S; van Amerongen G; Moss B; Niesters HG; Osterhaus AD; de Swart RL
    Vaccine; 2004 Feb; 22(8):923-6. PubMed ID: 15161069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of syngeneic tumor growth in vaccinia virus-primed mice by immunization with vaccinia virus-modulated tumor cells.
    Wu KS; Ueda S; Sakaue Y; Ohashi Y; Ikuta K; Sugano T; Kato S
    Biken J; 1981 Dec; 24(4):153-8. PubMed ID: 7346041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.
    Hu SL; Stallard V; Abrams K; Barber GN; Kuller L; Langlois AJ; Morton WR; Benveniste RE
    J Med Primatol; 1993; 22(2-3):92-9. PubMed ID: 8411113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.